AMAG Pharma (AMAG) Updates FY15 Expectations at Jefferies Healthcare Conference
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) is presenting at the Jefferies 2015 Global Healthcare Conference today. In part, the company updated certain FY15 metrics.
-- GAAP net income: $75 - $90 million
-- EBITDA: $200 - $220 million
-- Adjusted EBITDA: $200 - $220 million
-- Cash earnings: $170 - $190 million
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
- Northrim BanCorp (NRIM) Tops Q1 EPS by 54c
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
Jefferies & Co, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
